Literature DB >> 6531523

Perfluoroether liquid as a long-term vitreous substitute. An experimental study.

K Miyamoto, M F Refojo, F I Tolentino, G A Fournier, D M Albert.   

Abstract

A commercial perfluoroether liquid, Fomblin-H Fluorinated Fluid, which is transparent and viscous, was investigated as a possible long-term vitreous substitute. The material belongs to a family of perfluorocarbon derivatives that are generally inert and nontoxic. A space for the vitreous substitute was created in rabbit eyes by a vitreous compression technique using perfluoropropane gas. Fomblin caused gliosis of the retina at 1 month after intravitreous injection. Preretinal membrane formation and retinal disorganization and detachment occurred in two of four eyes enucleated at 3 months, and in all five eyes enucleated at 4 or 6 months. Vacuoles presumably filled with Fomblin were localized histopathologically within the retina. In control eyes injected with medical-grade silicone oil, abnormalities were limited to moderate edema of the nerve fiber and ganglion cell layer. Fomblin was not as well-tolerated by the rabbit retina as was medical-grade silicone oil. Fomblin is not a suitable vitreous substitute.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6531523     DOI: 10.1097/00006982-198400440-00010

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  16 in total

1.  Perfluorocarbon heavy liquids in the management of posterior dislocation of the lens nucleus during phakoemulsification.

Authors:  N J Rowson; A S Bacon; P H Rosen
Journal:  Br J Ophthalmol       Date:  1992-03       Impact factor: 4.638

2.  First experiences with high-density silicone oil (Densiron) as an intraocular tamponade in complex retinal detachment.

Authors:  Dirk Sandner; Katrin Engelmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-05       Impact factor: 3.117

Review 3.  [Current importance of heavy fluids as intraoperative aids in vitreoretinal surgery].

Authors:  Nicolas Feltgen; Hans Hoerauf
Journal:  Ophthalmologe       Date:  2019-10       Impact factor: 1.059

4.  Fluorosilicone oil in the treatment of retinal detachment.

Authors:  C M Gremillion; G A Peyman; K R Liu; K S Naguib
Journal:  Br J Ophthalmol       Date:  1990-11       Impact factor: 4.638

5.  Safety and feasibility of a novel intravitreal tamponade using a silicone oil/acetyl-salicylic acid suspension for proliferative vitreoretinopathy: first results of the Austrian Clinical Multicenter Study.

Authors:  Martina Theresa Kralinger; Ulrike Stolba; Michaela Velikay; Stefan Egger; Susanne Binder; Andreas Wedrich; Anton Haas; Jean-Marie Parel; Gerhard Franz Kieselbach
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-04-28       Impact factor: 3.117

6.  Influence on membrane-mediated cell activation by vesicles of silicone oil or perfluorohexyloctane.

Authors:  Norbert Kociok; Claudia Gavranic; Bernd Kirchhof; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-10-27       Impact factor: 3.117

7.  Retinal detachment and degeneration in response to subretinal perfluorodecalin in rabbit eyes.

Authors:  L Berglin; J Ren; P V Algvere
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-04       Impact factor: 3.117

8.  The effect of specific gravity of perfluorocarbon liquid on the retina after experimental vitreous substitution.

Authors:  Ulrike Stolba; Katharina Krepler; Michaela Velikay-Parel; Susanne Binder
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-07-17       Impact factor: 3.117

9.  Perfluorocarbon liquids as postoperative short-term vitreous substitutes in complicated retinal detachment.

Authors:  F Bottoni; M Sborgia; P Arpa; N De Casa; E Bertazzi; M Monticelli; V De Molfetta
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-11       Impact factor: 3.117

10.  Vitreon, a short-term vitreoretinal tamponade.

Authors:  K J Blinder; G A Peyman; U R Desai; N C Nelson; W Alturki; C L Paris
Journal:  Br J Ophthalmol       Date:  1992-09       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.